Purified bovine plasma blocking factor decreases bovine leukemia virus p24 expression while increasing protein synthesis and transcriptional activity of peripheral blood mononuclear cells in short-term culture

Canadian Journal of Veterinary Research

Volumn 69, Issue 3, 2005, Pages 186-192

  van den Heuvel, Marianne J ^a,b   Jefferson, Barbara J ^a   Jacobs, Robert M ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PLASMA BLOCKING FACTOR; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BOVINE LEUKEMIA VIRUS; CATTLE DISEASE; CELL DIVISION; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION REGULATION; IN VIVO STUDY; LYMPHOCYTE CULTURE; LYMPHOSARCOMA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT INFECTION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; TRANSCRIPTION INITIATION; UPREGULATION; VIRUS INFECTION;

ANIMALS; ANTIGENS, NEOPLASM; CATTLE; CELLS, CULTURED; ENZOOTIC BOVINE LEUKOSIS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; LEUKEMIA VIRUS, BOVINE; LEUKOCYTES, MONONUCLEAR; PLASMA; SERUM ALBUMIN, BOVINE; VIRAL CORE PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE LEUKEMIA VIRUS; DNA VIRUSES;

EID: 23844434621     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Schwartz I, Levy D. Pathobiology of bovine leukemia virus. Vet Res 1994;25:521-536.
2. Derse D. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements. J Virol 1987;61:2462-2471.
3. Burny A, Bex F, Chantrenne H, et al. Bovine leukemia virus involvement in enzootic bovine leukosis. Adv Cancer Res 1978;28:251-311.
4. Kettmann R, Marbaix G, Cleuter Y, Portetelle D, Mammerickx M, Burny A. Genomic integraton of bovine leukemia provirus and lack of viral RNA expression in the target cells of cattle with different responses to BLV infection. Leuk Res 1980;4: 509-519.
5. Merezak C, Pierreux C, Adam E, et al. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency. J Virol 2001; 75:6977-6988.
6. Miller JM, Miller LD, Olson C, Gillette KG. Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J Natl Cancer Inst 1969; 43:1297-1305.
7. Meirom R, Moss S, Brenner J, Heller D, Trainin Z. Levels and role of cytokines in bovine leukemia virus (BLV) infection. Leukemia 1997;11:219-220.
8. Zandomeni RO, Esteban E, Carrera-Zandomeni M, Ferrer JF. Host soluble factors with blocking and stimulating activity on the expression of the bovine leukemia virus. J Infect Dis 1994;170:787-794.
9. Gupta P, Kashmiri SV, Ferrer JF. Transcriptional control of the bovine leukemia virus genome: role and characterization of a non-immunoglobulin plasma protein from bovine leukemia virus-infected cattle. J Virol 1984;50:267-270.
10. Gupta P, Ferrer JF. Expression of bovine leukemia virus genome is blocked by a nonimmunoglobulin protein in plasma from infected cattle [published erratum appears in Science 1989; 244:632]. Science 1982;215:405-407.
11. Cornil I, Levy D. In vivo inhibition of bovine leukemia virus (BLV) expression. Leukemia 1989;3:159-161.
12. Haynes BF, Miller SE, Palker TJ, et al. Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. Proc Natl Acad Sci USA 1983;80:2054-2058.
13. Mackewicz C, Levy JA. CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res Hum Retroviruses 1992;8:1039-1050.
14. Gupta P, Chatterjee R, Cai Q. Prevalence of the plasma bovine leukaemia virus blocking factor in cattle from a commercial dairy herd. Vet Rec 1989;125:5-6.
15. Taylor JA, Jacobs RM. Effects of plasma and serum on the in vitro expression of bovine leukemia virus. Lab Invest 1993;69: 340-346.
16. Tsukiyama K, Onuma M, Izawa H. Effect of platelet-derived factor on expression of bovine leukemia virus genome. Arch Virol 1987;96:89-96.
17. Portetelle D, Mammerickx M, Burny A. Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51. J Virol Methods 1989;23:211-222.
18. van den Heuvel M, Portetelle D, Jefferson B, Jacobs RM. Adaptation of a sandwich enzyme-linked immunosorbent assay to determine the concentration of bovine leukemia virus p24 and optimal conditions for p24 expression in short-term cultures of peripheral blood mononuclear cells. J Virol Methods 2003; 111:61-67.
19. Bruschke CJ, Hulst MM, Moormann RJ, van Rijn PA, van Oirschot JT. Glycoprotein Erns of pestiviruses induces apoptosis in lymphocytes of several species. J Virol 1997;71: 6692-6696.
20. van den Heuvel MJ, Jefferson BJ, Jacobs RM. Isolation of bovine plasma fibronectin-containing complex which inhibits the expression of bovine leukemia virus p24. J Virol 2005;79:8164-8170.
21. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-5121.
22. Trueblood ES, Brown WC, Palmer GH, Davis WC, Stone DM, McElwain TF. B-lymphocyte proliferation during bovine leukemia virus-induced persistent lymphocytosis is enhanced by T-lymphocyte-derived interleukin-2. J Virol 1998;72:3169-3177.
23. Pyeon D, Diaz FJ, Splitter GA. Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus. J Virol 2000;74:5740-5745.
24. Stone DM, Hof AJ, Davis WC. Up-regulation of IL-2 receptor alpha and MHC class II expression on lymphocyte subpopulations from bovine leukemia virus infected lymphocytotic cows. Vet Immunol Immunopathol 1995;48:65-76.
25. Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR, Greene WC. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science 1988;241:1652-1655.
26. Kim SJ, Kehrl JH, Burton J, et al. Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia. J Exp Med 1990;172:121-129.
27. Lindholm PF, Reid RL, Brady JN. Extracellular Tax1 protein stimulates tumor necrosis factor-beta and immunoglobulin kappa light chain expression in lymphoid cells. J Virol 1992; 66:1294-1302.
28. Wakasaki H, Ooshima A. Immunohistochemical localization of lysyl oxidase with monoclonal antibodies. Lab Invest 1990; 63:377-384.
29. Harumiya S, Takeda K, Sugiura T, et al. Characterization of ficolins as novel elastin-binding proteins and molecular cloning of human ficolin-1. J Biochem (Tokyo) 1996;120:745-751.
30. Bugeja MJ, Booth DR, Bennetts BH, Guerin J, Kaldor JM, Stewart GJ. Analysis of the CCL3-L1 gene for association with HIV-1 susceptibility and disease progression. AIDS 2004;18: 1069-1071.
31. Schmidt HH, Behrens G, Genschel J, et al. Lipid evaluation in HIV-1-positive patients treated with protease inhibitors. Antivir Ther 1999;4:163-170.